Top takeaways from American Diabetes Association Scientific Sessions

The American Diabetes Association 77th Scientific Sessions recently wrapped in San Diego. Topics discussed included lowering cardiovascular risks in patients with type 2 diabetes, improving diabetes-related depression, managing and preventing diabetes during pregnancy and more.

As a service to its readers, Healio Internal Medicine presents the top news articles from the meeting.

Canagliflozin reduces risk for CVD, kidney disease in patients with type 2 diabetes

Patients with type 2 diabetes at high risk for cardiovascular disease assigned the SGLT2 inhibitor canagliflozin saw a 33% reduction in risk for hospitalization for heart failure and were 40% less likely to experience renal decline vs. those assigned placebo, according to findings from the integrated CANVAS study presented here. Read More.

PCSK9 inhibitor lowers CV risk in insulin-treated type 2 diabetes

Results of the ODYSSEY DM-INSULIN trial indicate that adults with dyslipidemia and type 2 diabetes who are taking insulin can reduce their cardiovascular risk with alirocumab, according to new data presented here. Read More.

Counseling, exercise combination effective for improving depressive symptoms, HbA1c

Adults assigned to counseling alone, exercise alone or a combination of both demonstrated improvements in depressive symptoms and diabetes-related distress, according to data from the Program ACTIVE trial. Read More.

Global burden of diabetes complications ‘substantial,’ continues to grow

The global burden of microvascular and macrovascular complications in adults with type 2 diabetes is relatively high and is expected to grow as the prevalence of diabetes increases, according to a speaker here. Read More.

Cumulative incidence of renal failure increases with longer type 1 diabetes duration

Duration of diabetes greatly affects the occurrence of advanced renal disease in older adults with type 1 diabetes, and decline in estimated glomerular filtration rate rather than genetics may help determine who is at risk later in life, a speaker said here. Read More.

Probiotics ineffective for preventing gestational diabetes in women with overweight, obesity

Pregnant women with overweight or obesity assigned to probiotic supplements beginning at 16 weeks’ gestation may not have a decreased risk for gestational diabetes compared with women who do not take supplements, according to a speaker here. Read More.

Multiple daily insulin injections during pregnancy may decrease adverse outcomes

Multiple daily insulin injections may be more effective than insulin pump use during pregnancy for lowering HbA1c and preventing adverse obstetric and neonatal outcomes, according to new data from the CONCEPTT trial. Read More.

Providers critical to patients’ willingness to adopt diabetes technology

Diabetes providers’ comfort with diabetes technology and beliefs about their patients’ comfort greatly influence the adoption of continuous glucose monitoring, according to a speaker here. Read More.

VIDEO: Health care disparities in diabetes require action from providers, patients

In this video exclusive, Harsimran Singh, PhD, a health psychologist and a clinical research scientist at the Mary & Dick Allen Diabetes Center at Hoag Memorial Hospital Presbyterian in Newport Beach, California, describes two important ways to address health care disparities among different patient populations with diabetes. Read More.